Axsome Therapeutics (19X) Q2 2022 Earnings Report
5 Followers
DE:19X Q2 2022 EPS Results
- Actual EPS
- -EUR 0.95
- Consensus EPS
- -EUR 0.90
- Beat/Miss
- Missed by -EUR 0.05
- One Year Ago EPS
- -EUR 0.77
DE:19X Q2 2022 Revenue Results
- Actual Revenue
- EUR 7.87M
- Expected Revenue
- EUR 6.17M
- Beat/Miss
- Beat by +EUR 1.70M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/09/2022
- Time
- Before Open
- Conference Call
- Tuesday, August 9, 2022
DE:19X Upcoming Earnings
Axsome Therapeutics's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:19X Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | -0.07- | -0.5 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.57-0.22 | -0.84 | 73.40% (+0.62) | |
| Aug 10, 2026 | 2026 (Q2) | -0.80-0.88 | -0.87 | -2.06% (-0.02) | |
| May 04, 2026 | 2026 (Q1) | -0.75-1.12 | -1.09 | -3.28% (-0.04) | |
| Feb 23, 2026 | 2025 (Q4) | -0.62-0.50 | -1.37 | 63.64% (+0.87) | |
| Nov 03, 2025 | 2025 (Q3) | -0.77-0.84 | -1.2 | 29.85% (+0.36) | |
| Aug 04, 2025 | 2025 (Q2) | -0.94-0.87 | -1.49 | 41.92% (+0.62) | |
| May 05, 2025 | 2025 (Q1) | -1.21-1.09 | -1.28 | 15.28% (+0.20) | |
| Feb 18, 2025 | 2024 (Q4) | -0.89-1.37 | -1.86 | 25.96% (+0.48) | |
| Nov 12, 2024 | 2024 (Q3) | -1.23-1.20 | -1.18 | -1.52% (-0.02) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
